Calton & Associates’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-2,500
| Closed | -$220K | – | 360 |
|
|
2021
Q4 | $220K | Buy |
+2,500
| New | +$220K | 0.06% | 330 |
|
|
2021
Q3 | – | Sell |
-2,526
| Closed | -$211K | – | 403 |
|
|
2021
Q2 | $211K | Buy |
+2,526
| New | +$211K | 0.04% | 377 |
|
|
2021
Q1 | – | Sell |
-2,607
| Closed | -$229K | – | 404 |
|
|
2020
Q4 | $229K | Buy |
+2,607
| New | +$229K | 0.04% | 335 |
|
|
2020
Q3 | – | Sell |
-1,693
| Closed | -$209K | – | 350 |
|
|
2020
Q2 | $209K | Buy |
+1,693
| New | +$209K | 0.05% | 297 |
|
|
2018
Q1 | – | Sell |
-43
| Closed | -$3K | – | 449 |
|
|
2017
Q4 | $3K | Buy |
+43
| New | +$3K | ﹤0.01% | 1300 |
|